Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Confirmatory placebo-controlled study of roflumilast (APTA-2217) in adult patients with bronchial asthma
jRCT2080220094
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in asthma comparing Roflumilast with Placebo (2 arms).
02
Drugs
roflumilast
03
Conditions
asthma
Beyond the preview
Go deeper on jRCT2080220094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220094.